WHO ICTRP trial

Comparing the Efficacy of Odansetron, Ramosetron and Dexamethasone in preventing…

CTRI/2021/11/037930 · Clinical Trials Registry India (CTRI) · Recruiting

Key facts

Trial ID CTRI/2021/11/037930
Public title Comparing the Efficacy of Odansetron, Ramosetron and Dexamethasone in preventing nausea and vomiting following general anesthesia in orthopaedic surgery
Scientific title A Single Centre Prospective Randomised Study Comparing the Efficacy of Odansetron and Ramosetron with Dexamethasone as an adjunct in Preventing Post Operative Nausea and Vomiting in Patients undergoing Orthopaedic Surgery under General Anesthesia in India
Primary sponsor DR PREETHI RAJSRI ANANDHAN
Registry Clinical Trials Registry India (CTRI)
Recruitment status Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Interventions Intervention1: Odansetron: 4mg intravenous single dose given before induction of general anesthesia Control Intervention1: Ramosetron: 0.3mg intravenous single dose given before induction of general anesthesia
Registration date Oct 11, 2021
Target size 100
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations